MEDICINES BENEFIT-RISK ASSESSMENT
DESCRIPTION
This course domain covers the Introduction to benefit-risk assessment and pharmacoeconomics in decision making, the Principles of pharmacoeconomics and valuation of health states, the Fundamentals of quantitative benefit-risk assessment methods in decision making on medicines and the Advanced quantitative benefit-risk assessment methods in decision making on medicines.
medicines, benefit-risk assessment
OBJECTIVES
- To obtain overview/basic insight into benefit-risk assessment methods (including pharmacoeconomics), the process of decision making on medicines by different stakeholders
- To obtain detailed insight into benefit-risk assessment methods (including pharmacoeconomics), the process of decision making on medicines by different stakeholders
- To be able to apply benefit-risk assessment methods in daily practice
ACADEMIC SUPERVISION
|
ASSOCIATED PARTNERSHIP
Developed with the Pharma Industry expertise of F. Hoffmann-La Roche Ltd, H. Lundbeck A/S, Janssen Pharmaceutica NV, Laboratorios Almirall SA. |
GUIDES
Eu2P COURSE DOMAINS
Confused? Read the FAQs...